MET and Miyoshi myopathy: Inhibition of MET, the most MM-relevant non-ALK/LTK target for crizotinib, would not induce ER-stress [51] nor cause M protein retention, but may play a role in inhibiting MM responses to HGF including reduced proliferation, and microenvironment effects [52].